Developing Immune Profiling Solutions and T-Cell Diagnostics
Developing a Novel Portfolio of FluoroSpot T-Cell Diagnostics for Indications Associated with Chronic Inflammation and T Cell Exhaustion
Investigate T Cell Immunity
Vaccine Efficacy Testing
Following vaccination, the immune system generates a primary immune response, which includes the production of antibodies specific to the target pathogen. These antibodies are effective at neutralizing the pathogen, but their levels typically decline over time once the immediate threat is absent.
In contrast, memory T cells form a long-lasting immunological memory. Although antibody levels wane, memory T cells persist in the body for years and their presence ensures that the immune system responds more effectively upon re-exposure to the antigen.
Our state-of-the-art techniques and expertise allow us to provide crucial data on the activation, expansion, and persistence of memory T cells after vaccination. These insights ensure that immunizations are not only effective in the short term, but also capable of providing durable, long-lasting immunity.
At Virax Biolabs, we’re more than just a service provider – as your dedicated partner, we are committed to accelerating the path to more effective vaccines to create lasting, impactful change in global health. Get in touch to find out what we can do for you and your vaccine development.
Research Tools to Investigate T Cell Immunity
ViraxImmune™ Products
Peptide Pools
Pathogen-specific linear peptides containing immunodominant epitopes, designed for efficient T cell stimulation.
ELISpot/FluoroSpot Kits
Pre-coated plates and reagents to analyse the immune response at cellular level. Multiple cytokines available.
Antibodies
High-affinity antibodies for the detection of cytokines and other biomarker in ELISA, Flow cytometry and ELISpot assays.
T Cell Testing
ELISpot assays are one of the most sensitive and specific techniques available for monitoring T cell responses permitting the ex vivo identification of cells actively secreting signaling proteins or antibodies. In addition the assay is relatively fast, highly efficient and the limit of detection achieved 1 in 100,000 cells.
Diagnosis of Viral Diseases
Immune Profiling is the detailed study and characterization of both the innate and adaptive immune responses to provide crucial insights into disease mechanisms and aiding in the development of novel therapeutic strategies. Our ViraxImmune™ IVD platform is not restricted to a single disease or condition.
Find out more about our company activites
Latest News and Media
Tune in now to listen to Dr. Nigel McCracken talk about “The Power of T Cell Immunology: Early Diagnosis, Immunotherapy, & the Future of Global Health” on the Finding Genius podcast
Join us for Inside Precision Medicine’s FREE State of Precision Medicine Summit on Wednesday, March 5th, 2025.
One of the key highlights is the “State of Molecular Diagnostics” panel at 2:30pm EST, featuring industry leaders including Virax Biolab’s COO, Dr Nigel McCracken, and moderated by North American
“Preparing for Potential Vaccine Regulatory Changes”: Virax CEO, James Foster, discusses how the industry is preparing for potential regulatory changes to vaccine policy
Article by Mike Hollan
Virax Biolabs Believes Technology Aligns with Unites States Department of Health and Human Services’ Transparency Priority on Vaccine Efficacy
“What Does 2025 Hold For Biopharma? Part 6: Therapeutic Area Advances”: Industry leaders including Virax CEO, James Foster, share their expectations for the year ahead
Article by Eleanor Malone
Sign up for more information about our products and company updates